Atlas Trials

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

Clinical trial NCT00107263 · COMPLETED

Trial details

NCT number
NCT00107263
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast CancerOsteoporosis
Start date
2005-01-01
Primary completion
2007-03-01
Enrollment
558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.